NCT02794610

Ocular Penetration of Topical Tacrolimus Eye Drops

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: The Eye Center and The Eye Foundation for Research in Ophthalmology · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops. Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.

Conditions

• Ocular Penetration of Topical Tacrolimus

Interventions

Type	Name	Description
DRUG	Tacrolimus	Topical tacrolimus 0.05% eye drops will be instilled into the eyes of patients every minute for 5 minutes. After 15 minutes, at the time of cataract surgery, aqueous samples will be collected and will be subjected to detection of presence and level of tacrolimus.

Timeline

• Start date: 2016-05-01
• Primary completion: 2016-06-01
• Completion: 2016-07-01
• First posted: 2016-06-09
• Last updated: 2016-06-09

Locations

1 site across 1 country: Saudi Arabia